当前位置:首页>产品中心>单抗/多抗>Anti-galactose-deficient IgA1 Recombinant Antibody|抗半乳糖缺陷型IgA1重组抗体(靶标:半乳糖缺陷型IgA1)

Anti-galactose-deficient IgA1 Recombinant Antibody|抗半乳糖缺陷型IgA1重组抗体(靶标:半乳糖缺陷型IgA1)

  • 货号:RB9THV621013
  • 价格:面议
  • 点击:341

产品介绍

产品参数

形态Liquid
宿主种属Rat
克隆性Monoclonal
抗体亚型IgG2b, kappa
纯度>95% as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
内毒素水平Please contact with the lab for this information.
应用ELISA, IF, IHC
种属反应性Homo sapiens (Human)
靶标galactose-deficient IgA1, Gd-IgA1, IGHA1, Ig alpha-1 chain C region, Ig alpha-1 chain C region BUR, Ig alpha-1 chain C region TRO, Immunoglobulin heavy constant alpha 1
储存缓冲液0.01M PBS pH 7.4
稳定性和储存Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
重构方法Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
登录号P01876
背景信息

Immunoglobulin heavy constant alpha 1 (Gd-IgA1) is a ~42 kDa protein. Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain.

1. Schroeder, HW. et al. (2010) The Journal of allergy and clinical immunology 125, S41-52. PMID: 20176268
2. McHeyzer-Williams, M. et al. (2011) Nature reviews. Immunology 12, 24-34. PMID: 22158414
3. Teng, G. et al. (2007) Annual review of genetics 41, 107-20. PMID: 17576170
4. Kerr, MA. (1990) The Biochemical journal 271, 285-96. PMID: 2241915
备注For research use only
【仅供科学研究使用】

相关产品:
产品名称 点击数
Research Grade Lunaxafusp|研究级Lunaxafusp(靶标:Lunaxafusp(研究用)) 522
Anti-Mouse C5 Recombinant Antibody|抗小鼠C5重组抗体(靶标:小鼠补体C5) 404
Anti-Pembrolizumab Neutralizing Recombinant Antibody |抗帕博利珠单抗中和重组抗体(靶标:帕博利珠单抗中和抗体) 306
Anti-Pembrolizumab Neutralizing Recombinant Antibody |抗帕博利珠单抗中和重组抗体(靶标:帕博利珠单抗中和抗体) 206
Anti-Human CD39/ENTPD1 Recombinant Antibody|抗人CD39/ENTPD1重组抗体(靶标:人外核苷酸三磷酸二磷酸水解酶1/CD39) 283
Anti-Glycophorin A (type M) Recombinant Antibody|抗血型糖蛋白A(M型)重组抗体(靶标:人血型糖蛋白A(M型)) 591
Anti-Glycophorin A (type N) Recombinant Antibody|抗血型糖蛋白A(N型)重组抗体(靶标:人血型糖蛋白A(N型)) 256
Anti-Glycophorin A (type N) Recombinant Antibody|抗血型糖蛋白A(N型)重组抗体(靶标:人血型糖蛋白A(N型)) 510
Anti-Glycophorin A (type M) Recombinant Antibody|抗血型糖蛋白A(M型)重组抗体(靶标:人血型糖蛋白A(M型)) 304
Anti-Human α4β7/ITGA4 & ITGB7 Recombinant Antibody |抗人α4β7/ITGA4和ITGB7重组抗体(靶标:人整合素α4β7复合物) 266
Anti-Human CD2BP2 Polyclonal Antibody|抗人CD2BP2多克隆抗体(靶标:人CD2结合蛋白2) 444
InVivoMAb anti-Mouse IL-6R alpha&IL6R Antibody|InVivoMAb抗小鼠IL-6Rα和IL6R抗体(靶标:小鼠白细胞介素6受体) 512
Anti-Human EGFR/ERBB1/HER1 Reference Antibody|抗人EGFR/ERBB1/HER1参照抗体(靶标:人表皮生长因子受体(研究用)) 410
Anti-Human CD279/PD-1 Recombinant Antibody|抗人CD279/PD-1重组抗体(靶标:人程序性细胞死亡蛋白1/PD-1) 493
Anti-Human CD279/PD-1 Recombinant Antibody, FITC|抗人CD279/PD-1重组抗体, FITC标记(靶标:人程序性细胞死亡蛋白1/PD-1(FITC标记)) 511
Anti-Human CD279/PD-1 Recombinant Antibody, PE|抗人CD279/PD-1重组抗体, PE标记(靶标:人程序性细胞死亡蛋白1/PD-1(PE标记)) 409
Anti-Human CD279/PD-1 Recombinant Antibody, APC|抗人CD279/PD-1重组抗体, APC标记(靶标:人程序性细胞死亡蛋白1/PD-1(APC标记)) 631
Anti-Human CD279/PD-1 Recombinant Antibody, PerCP|抗人CD279/PD-1重组抗体, PerCP标记(靶标:人程序性细胞死亡蛋白1/PD-1(PerCP标记)) 501
Anti-Omalizumab Neutralizing Recombinant Antibody |抗奥马珠单抗中和重组抗体(靶标:奥马珠单抗中和抗体) 282
Anti-Omalizumab Neutralizing Recombinant Antibody |抗奥马珠单抗中和重组抗体(靶标:奥马珠单抗中和抗体) 217
总计 33037 个记录,共 1652 页,当前第 1643 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周五每天9:00-17:00